Remind Me

Terms of use

1. General Conditions
This website is owned and operated by CSL Biotherapies (NZ) Ltd ("CSL, we or us"). Your access to this website is conditional on your acceptance and compliance with the terms, conditions, notices and disclaimers contained on this page and elsewhere on the website. CSL reserves the right to amend the General Conditions at any time.

2. Copyright
Unless indicated to the contrary, CSL owns all copyright subsisting in the information, text, materials, graphics, software, names, logos and trademarks (the "Content") contained on this website. CSL hereby authorizes you to copy materials published by CSL on this Web site for personal, non-commercial use only, provided you reproduce in whole or in part the Content only and material is kept intact and in the same form as presented on this website (including all copyright, trademark and other proprietary notices). Each CSL and CSL site to which this site links remains subject to its own copyright notice. These materials cannot be distributed, modified, posted on a Web site.

3. Trade Marks
Unless indicated to the contrary the trademarks contained on this website are trademarks of CSL or its subsidiaries. Where a mark is indicated as a registered mark it is registered in New Zealand and may also be registered in other jurisdictions. Nothing contained in this website is to be construed as a licence or any right to use a trademark displayed on this website without the express written permission of CSL.

4. Links
This website contains links to third party websites. These linked websites are not under the control of CSL and CSL is not responsible for the contents of any linked websites or any hyperlink contained in any linked websites. CSL provides these links as a convenience only and the inclusion of any link does not imply any endorsement of the linked website by CSL. You link to any linked websites entirely at your own risk.

5. Disclaimer
The Content contained on this website is provided for general information only. It should not be relied upon without obtaining specific advice from appropriate experts. While CSL has used reasonable efforts to ensure that the Content contained on this website is correct and current at the time it is published, CSL makes no representation and gives no warranty that the Content contained on this website is complete or accurate and takes no responsibility for any error, omission or defect in such Content.

This website may contain forward looking statements. Such statements are subject to many factors which may cause CSL plans or results to differ from those expected. These include unexpected preclinical or clinical results, the need for additional research and development, delays in manufacturing, access to capital and funding and delays in the development of commercial relationships. CSL undertakes no obligation to publicly release or update the results of any forward looking statements which may be made to reflect events or circumstances including the occurrence of unanticipated events after the date at which those statements are made.

6. Limitation of Liability
To the maximum extent permitted by law, CSL disclaims any liability to any person arising out of any action or failure to act by that person, in accessing, downloading, using or relying on any Content contained on this website whether caused by the negligence of CSL or otherwise. Under no circumstances will CSL be liable for any indirect, incidental, special or consequential damages, including loss of business or other profits, arising in relation to the use of any Content contained in this website whether caused by the negligence of CSL or otherwise.

7. Virus Warning
CSL does not represent or warrant that any files obtained from or through this website are free from computer viruses or other defects. Any such files are provided and may be used on the basis that the user accepts all responsibility for any loss, damage or other consequence resulting directly or indirectly from the use of those files.

8. Governing Law
These General Conditions are governed by, construed and enforced in accordance with the laws of New Zealand. Any disputes arising from these General Conditions or in connection with the use of this website are subject to the exclusive jurisdiction of the courts of New Zealand.

This website may be accessed throughout New Zealand and overseas. CSL makes no representation that the Content on this website complies with the laws of any country outside New Zealand. If you access this site from outside New Zealand, you are responsible for ensuring that that your access to, downloading of, use of or reliance on the Content contained in this website is in compliance with all laws in the place in which you are located.

Immunisation does not replace the need for regular cervical smear testing.

*Girls aged 9 up to those born on or after 1 January 1990 are eligible for free immunisation through a doctor, medical clinic or school based programme. A patient charge applies for all ages outside this range.

GARDASIL™ [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine] GARDASIL is a prescription medicine that is fully funded for females born between 1 January 1990 and 31 December 1999. Please refer to the Ministry of Health for the eligibility criteria for girls younger than 11. A patient charge applies for all others outside this range. Indication: GARDASIL is a vaccine that helps prevent the following diseases caused by Human Papillomavirus (HPV) Types 6, 11, 16 or 18: cervical cancer (cancer of the lower end of the uterus or womb), vulvar (the outside of the female genitals) and vaginal cancers, abnormal and precancerous cervical lesions (changes in cells of the cervix which have a risk of turning into cancer) as found by a Pap test, genital warts, and HPV infection. GARDASIL helps prevent, but does not treat these diseases. You cannot get these diseases from GARDASIL. GARDASIL can be given to females aged 9 to 45 years and males aged 9 to 15 years. Contraindications: Do not, or do not let your child have GARDASIL if you or your child have had an allergy to any of the ingredients or if you or your child have had an allergic reaction after receiving a dose of the vaccine. If you are not sure whether you or your child should be given GARDASIL, talk to your doctor or health care provider. Warnings and Precautions: Tell your doctor or health care provider if you or your child: has had an allergic reaction to the vaccine, has a bleeding disorder and cannot receive injections in the arm, has any illness with a fever higher than 100°F (37.8°C), is pregnant or is planning to get pregnant, takes or plans to take any medicines, including ones you buy without a prescription from your pharmacy, supermarket, or health food shop, has a weakened immune system, for example due to a genetic defect or Human Immunodeficiency Virus (HIV) infection. Adverse Reactions: Tell your doctor or pharmacist as soon as possible if you or your child do not feel well during or after having had an injection of GARDASIL. Tell your doctor if you or your child have any of the following and they are troublesome or ongoing: pain, itching, tenderness, or soreness at the injection site, local reaction around the injection site such as soreness, redness, or swelling, fever, dizziness, nausea and vomiting, pain in the extremities. Fainting, sometimes accompanied by shaking or stiffening, has been reported. Although fainting episodes are uncommon, patients should be observed for 15 minutes after they receive HPV vaccination. As with other vaccines, side effects that have been reported during general use include: headache, swollen glands in the neck, armpit and groin, joint pain, aching muscles, unusual tiredness or weakness, chills, generally feeling unwell, and allergic reactions. If any of the above symptoms worsen or you or your child has any unusual or severe symptoms after receiving GARDASIL, contact your doctor or health care provider right away. Ingredients: The active ingredients of GARDASIL are highly purified inactive proteins from HPV Types 6, 11, 16 and 18.

For more information, please contact your health care provider or CSL Biotherapies (NZ) Ltd, PO Box 62 590, Central Park, Auckland 1544, Freephone 0800 502 757 or www.cslbiotherapies.co.nz. GARDASIL™ is a registered trademark of Merck & Co. Inc. Whitehouse Station, NJ, 08889 USA. GARD-143-09/09 TAPS CH2448 Date of Preparation: September 2009.

Disclaimer: The information in this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding GARDASIL must be made with a healthcare provider. The product information provided in this site is intended for residents of New Zealand. Audiences outside New Zealand should refer to the product information in their own country, as different regulatory regimes may apply. GARDASIL is distributed in New Zealand by CSL Biotherapies (NZ) Ltd.